Empowering Patients With Diabetes: Medtronic Tempe's Life-Altering Technologies

Webmedtronic plc (nyse:mdt), a global leader in healthcare technology, today announced ce (conformité européenne) mark approval for the minimed™ 780g system. Continuous glucose monitoring (cgm) technology offers primary care providers (pcps) access to additional data on patients’ glycemic status to inform. Webthe ultimate goal of caring for people with diabetes is to prevent complications from prolonged hyperglycemia while improving quality of life.

Webmedtronic diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced diabetes.